The Phase 3 study is evaluating two doses of Novo’s Wegovy pill in people with obesity or overweight in combination with a ...

By Bhanvi Satija and Michael Erman LONDON, Aug 19 (Reuters) - Danish drugmaker Novo Nordisk is testing smaller doses of its ...

Wegovy® HD demonstrated a mean weight loss of 20.7%1, and around one-third of patients achieved 25% or greater weight loss in the STEP UP trial First US FDA approval of a GLP-1 treatment under the ...

Daily oral GLP-1 medications Wegovy and Foundayo offer a convenient alternative to weight loss injections, but key differences in effectiveness, dosing and flexibility can help determine which option ...

Just eight months after it introduced its oral version of semaglutide for obesity, also known as the Wegovy pill, Novo ...

Novo Nordisk is testing whether lower maintenance doses of the drug can still help people lose weight in a new ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

MOVE over fat jabs – there’s a new weight loss ‘wonder’ in town. The Wegovy tablet is now officially on sale in the UK, costing around £25 a week. It’s the first of a new generation of GLP-1 ...

Shifting from weekly glucagon-like peptide-1 (GLP-1) receptor agonist injections to a daily oral medication may be a game-changer for people looking to lose weight, especially those who feel hesitant ...

PLAINSBORO, N.J., March 19, 2026 /PRNewswire/ -- Novo Nordisk today announced US Food and Drug Administration (FDA) approval of a new higher dose of Wegovy®, Wegovy® HD (semaglutide) injection 7.2 mg, ...

The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – became the first GLP-1 available to buy as a daily pill. Wegovy was ...

First US FDA approval of a GLP-1 treatment under the Commissioner's National Priority Voucher pilot programme, for products addressing critical US national health priorities Wegovy® HD complements ...